, Tracking Stock Market Picks
Enter Symbol:
Iris International, Inc. (IRIS) [hlAlert]

up 80.53 %

Iris International, Inc. (IRIS) rated Outperform with price target $14 by Northland Securities

Posted on: Wednesday,  Mar 25, 2009  8:25 AM ET by Northland Securities

Northland Securities rated Outperform Iris International, Inc. (NASDAQ: IRIS) on 03/25/2009, when the stock price was $10.79. Since
then, Iris International, Inc. has gained 80.54% as of 10/31/2016's recent price of $19.48.
If you would have followed this Northland Securities's recommendation on IRIS, you would have gained 80.53% of your investment in 2777 days.

IRIS International, Inc. develops, manufactures and markets in vitro diagnostic (IVD) products, including IVD imaging systems based on neural network-based automated particle recognition (APR) software to enable high-speed digital processing to classify and display images and describe the morphology of microscopic particles, urine chemistry analyzer and related chemistry test strips and accessories, molecular diagnostics assays based on its nucleic acid detection immuno-assay (NADiA) technology, as well as special purpose centrifuges and other small instruments for automating microscopic procedures and deoxyribonucleic acid (DNA) processing performed in clinical laboratories. Its commercialized products and product pipeline comprise three categories: morphology, molecular diagnostics and sample processing.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2009 8:25 AM Buy
10.79 14.00
as of 12/31/2009
1 Week down  -21.26 %
1 Month down  -15.35 %
3 Months down  -16.10 %
1 YTD down  -12.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy